Pregnancy complicated by Lymphangioleiomyomatosis

Archives of Iranian Medicine

Volumn 12, Issue 2, 2009, Pages 182-185

  Gargari, Soraya Saleh ^a   Hantoushzadae, Sedigheh ^b   Mohamadi, Fourozan ^c   Jafar Abadi, Mina ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lung diseases; Lymphangioleiomyomatosis; Pregnancy

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DYSPNEA; ESTROGEN SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRAN; LUNG BIOPSY; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LYMPHANGIOLEIOMYOMATOSIS; PLEURODESIS; PREGNANCY; PREGNANCY COMPLICATION; SPONTANEOUS PNEUMOTHORAX; THORAX RADIOGRAPHY; LUNG; LUNG TUMOR; LYMPHANGIOMYOMA; PATHOLOGY;

ADULT; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHANGIOMYOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67649784709     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Seyama K, Kira S, Takahashi H, Ohnishi M, Kodama Y, Dambara T, et al. Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: diverse clinical courses of LAM allow some patients to be treated without antihormone therapy. Respirology. 2001; 6: 331-340.
2. National Heart, Lung, and Blood Institute. NHLBI Workshop Summary. Report of workshop on lymphangioleiomyomatosis. Am J Respir Crit Care Med. 1999; 156: 679-683.
3. Silverstein E, Ellis K, Wolff M, Jaretzki A 3rd. Pulmonary lymphangiomyomatosis. Am J Roentgenol Radium Ther Nucl Med. 1974; 120: 832-850.
4. Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med. 1990; 323: 1254-1260.
5. Kitaichi M, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995; 15: 527-533.
6. Kang H, Kim CJ, Kang SK, Lee KS, Lee CS, Kim YH. Pulmonary lymphangioleiomyomatosis in a male. J Korean Med Sci. 1991; 6: 83-85.
7. Kitzsteiner KA, Mallen RG. Pulmonary lymphangiomyomatosis: treatment with castration. Cancer. 1980; 46: 2248-2249.
8. Eliasson, AH, Phillips YY, Tenholder MF. Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest. 1989; 96: 1352-1355.
9. McCarty KS Jr, Mossler JA, McLelland R, Sieker HO. Pulmonary lymphangiomyomatosis responsive to progesterone. N Engl J Med. 1980; 303: 1461-1465.
10. Tomasian A, Greenberg MS, Rumerman H. Tamoxifen for lymphangioleiomyomatosis. N Engl J Med. 1982; 306: 745-746.
11. Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore). 1999; 78: 321-337.
12. Rossi GA, Balbi B, Oddera S, Lantero S, Ravazzoni C. Response to treatment with an analog of the luteinizinghormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis. Am Rev Respir Dis. 1991; 143: 174-176.
13. Adamson D, Heinrichs WL, Raybin DM, Raffin TA. Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone. Am Rev Respir Dis. 1985; 132: 916-921.
14. Sawicka EH, Morris AJ. A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy. Br J Dis Chest. 1985; 79: 400-406.
15. Taveira-DaSilva A, Steagall WK, Moss J. Lymphangioleiomyomatosis. Cancer Control. 2006; 13: 276-285.
16. Kinoshita M, Yokoyama T, Higuchi E, Yano H, Watanabe H, Rikimaru T, et al. Hormone receptors in pulmonary lymphangiomyomatosis. Kurume Med. 1995; 42: 141-144.